Heidi Health nabs $340M to deepen adoption of AI agents within health systems globally
SiliconANGLE Kyt Dotson ● Covered by 2 sources
Heidi Health raised $340 million to push its AI tools deeper into health systems. It’s betting doctors want help, not replacement, and early use is already broad.
Based on reporting by SiliconANGLE, Kyt Dotson — read the original for the full story.
Summary, retelling and take written by AI under human oversight; images are AI-generated illustrations. How we work · Report an error
Heidi Health Trading Pty Ltd. has raised $340 million to expand its AI push in healthcare and go deeper inside health systems. The money comes from two places: a $100 million Series C led by Blackbird, with Phoenix Court, Point72 Private Investments and Headline joining in, plus $240 million in growth investment from General Catalyst.
The company, founded in Melbourne, is pitching an “AI Care Partner” rather than a note-taking gimmick. Co-founder and chief executive Dr. Thomas Kelly says the bigger idea was always to put AI beside clinicians and have it do real work under supervision. That framing matters. Healthcare buyers have heard enough replacement talk.
Heidi’s main product, Scribe, listens in the background and turns conversations into patient histories, symptom records, multilingual support, and follow-up material such as coding suggestions and handouts. The company also offers Evidence, which gives doctors, nurses and other staff access to medical research at the point of care, pulling in patient details, lab results and live transcripts before generating summaries with citations and risk scoring. Heidi says Evidence has answered more than 10 million queries since launching in March.
The stack is getting broader. Heidi has also shipped Remote, a secure wearable device meant for clinical settings from surgery to community clinics, along with Dictate, its voice-to-text feature. Kelly says the goal is to ease the burden on clinicians and help drive adoption across U.S. health systems, and the company says its enterprise activation rate has been around 62% since its Series B in October across major public and private systems.
The customer list is already useful for sales decks. Beth Israel Lahey Health in Massachusetts uses Heidi, and NHS England Midlands selected it as the sole supplier for what Heidi says was the largest clinical AI procurement in NHS history. That’s the real story here: not just the money, but a company trying to turn “AI in healthcare” from a pilot into plumbing.
My take — AI-written commentary, not fact-checked reporting
This is the kind of AI story that actually matters: boring, embedded, and aimed at paperwork instead of cosplay replacement. The market keeps rewarding tools that sit inside real workflows and stay out of the doctor’s way, which is a healthy correction after years of grandstanding. The open question is whether health systems will keep buying practical automation once the demo glow wears off.
Read more about this at: SiliconANGLE